- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
May 18, 2020
Although the coronavirus pandemic has turned our worlds upside down, it’s important for you to land on your feet. We want to help. If you work in a medical research organization, you may have or slowed or paused projects because of social distancing, or you may have pivoted to accelerate work on coronavirus treatments, tests or vaccines.
May 7, 2020
When research is on hold, so, in some cases, are patients’ hopes for relief. That’s why it’s important to remember that even if you, as a researcher, are separated from your work, you can continue valuable activities in the background, e.g., project design, planning and preparation.
March 23, 2020
We hope you are safe and well and taking all necessary steps to stay that way. In a time like this, one marvels at how much effort has gone into medical progress over the centuries, as well as the importance of science now under way.
February 20, 2020
Life science researchers are increasingly discovering the value that iSpecimen’s Marketplace and its growing network of supply partners – hospitals, clinical labs, biobanks, blood collection centers, and healthy cell processing sites – provide by enabling increased access to large cohorts of specimens and annotated data, efficiently and in a scalable way.
January 21, 2020
Although January is just another month and the 2020s are just another decade, big changes in the calendar give us pause. As another year unfolds, I marvel at how far biomedical research has come and where it will take us in the next year and beyond.
October 10, 2019
Veteran health care informatics expert Benjamin Bielak recently joined iSpecimen as its first Chief Information Officer. He is the subject of our latest Q&A… The iSpecimen Marketplace is often compared to eBay or Amazon for clarity, but it’s certainly more complicated than that. What are the biggest technology challenges of an online marketplace not for […]
September 12, 2019
Liquid biopsies are among the most exciting areas of medical diagnostics. Although the technology is in its early stages, the hope is that liquid biopsies – through a simple draw of blood or other human biofluids – will detect cancer earlier and without the invasiveness of surgical or needle biopsies. The procedure could one day be simple and cost-effective enough to conduct in the doctor’s office or in the comfort of one’s own home, even before symptoms arise.
August 15, 2019
A disease is an abnormal condition, and to fully understand it, you need to compare abnormal biology against the normal. That’s the concept behind the matched sets of human biospecimens that we provide to researchers around the world.